Breast Cancer, Version 3.2020

被引：635

作者：

Gradishar, William J. ^{[1
]}

Anderson, Benjamin O. ^{[2
]}

Abraham, Jame ^{[3
,4
]}

Aft, Rebecca ^{[5
,6
]}

Agnese, Doreen ^{[7
,8
]}

Allison, Kimberly H. ^{[9
]}

Blair, Sarah L. ^{[10
]}

Burstein, Harold J. ^{[11
]}

Dang, Chau ^{[12
]}

Elias, Anthony D. ^{[13
]}

Giordano, Sharon H. ^{[14
]}

Goetz, Matthew P. ^{[15
]}

Goldstein, Lori J. ^{[16
]}

Isakoff, Steven J. ^{[17
]}

Krishnamurthy, Jairam ^{[18
]}

Lyons, Janice ^{[3
,4
]}

Marcom, P. Kelly ^{[19
]}

Matro, Jennifer ^{[20
]}

Mayer, Ingrid A. ^{[21
]}

Moran, Meena S. ^{[22
]}

Mortimer, Joanne ^{[23
]}

O'Regan, Ruth M. ^{[24
]}

Patel, Sameer A. ^{[16
]}

Pierce, Lori J. ^{[25
]}

Rugo, Hope S. ^{[26
]}

Sitapati, Amy ^{[10
]}

Smith, Karen Lisa ^{[27
]}

Smith, Mary Lou ^{[28
]}

Soliman, Hatem ^{[29
]}

Stringer-Reasor, Erica M. ^{[30
]}

Telli, Melinda L. ^{[9
]}

Ward, John H. ^{[31
]}

Young, Jessica S. ^{[32
]}

Burns, Jennifer L. ^{[33
]}

Kumar, Rashmi ^{[33
]}

机构：

[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[2] Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[3] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[4] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[5] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[6] Washington Univ, Sch Med, St Louis, MO USA

[7] Ohio State Univ, Comprehens Canc Ctr, James Canc Hosp, Columbus, OH 43210 USA

[8] Solove Res Inst, Columbus, OH USA

[9] Stanford Canc Inst, Stanford, CA USA

[10] UC San Diego Moores Canc Ctr, La Jolla, CA USA

[11] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[12] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[13] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[15] Mayo Clin, Canc Ctr, Rochester, MN USA

[16] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[17] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[18] Fred & Pamela Buffet Canc Ctr, Omaha, NE USA

[19] Duke Canc Inst, Durham, NC USA

[20] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[21] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[22] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[23] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[24] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[25] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[26] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[27] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[28] Res Advocacy Network, Plano, TX USA

[29] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[30] UAB, ONeal Comprehens Canc Ctr, Barcelona, Spain

[31] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[32] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[33] Natl Comprehens Canc Network, Plymouth Meeting, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2020年 / 18卷 / 04期

关键词：

PHASE-III TRIAL; FULVESTRANT; 500; MG; FIRST-LINE THERAPY; ANASTROZOLE; LAPATINIB PLUS CAPECITABINE; AROMATASE INHIBITOR THERAPY; PROGRESSION-FREE SURVIVAL; ALBUMIN-BOUND PACLITAXEL; SCALP COOLING DEVICE; EPOTHILONE-B ANALOG;

D O I：

10.6004/jnccn.2020.0016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Several new systemic therapy options have become available for patients with metastatic breast cancer, which have led to improvements in survival. In addition to patient and clinical factors, the treatment selection primarily depends on the tumor biology (hormone-receptor status and HER2-status). The NCCN Guidelines specific to the workup and treatment of patients with recurrent/stage IV breast cancer are discussed in this article.

引用

页码：452 / 478

页数：27

共 181 条

[21] Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer [J].

Bartsch, Rupert ;

Wenzel, Catharina ;

Altorjai, Gabriela ;

Pluschnig, Ursula ;

Rudas, Margaretha ;

Mader, Robert M. ;

Gnant, Michael ;

Zielinski, Christoph C. ;

Steger, Guenther G. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) :3853-3858

[22]

Baselga J, 2012, J CLIN ONCOL, V30

[23] Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer [J].

Baselga, Jose ;

Campone, Mario ;

Piccart, Martine ;

Burris, Howard A., III ;

Rugo, Hope S. ;

Sahmoud, Tarek ;

Noguchi, Shinzaburo ;

Gnant, Michael ;

Pritchard, Kathleen I. ;

Lebrun, Fabienne ;

Beck, J. Thaddeus ;

Ito, Yoshinori ;

Yardley, Denise ;

Deleu, Ines ;

Perez, Alejandra ;

Bachelot, Thomas ;

Vittori, Luc ;

Xu, Zhiying ;

Mukhopadhyay, Pabak ;

Lebwohl, David ;

Hortobagyi, Gabriel N. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (06) :520-529

[24] Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer [J].

Baselga, Jose ;

Cortes, Javier ;

Kim, Sung-Bae ;

Im, Seock-Ah ;

Hegg, Roberto ;

Im, Young-Hyuck ;

Roman, Laslo ;

Pedrini, Jose Luiz ;

Pienkowski, Tadeusz ;

Knott, Adam ;

Clark, Emma ;

Benyunes, Mark C. ;

Ross, Graham ;

Swain, Sandra M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) :109-119

[25] Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy [J].

Baselga, Jose ;

Gelmon, Karen A. ;

Verma, Shailendra ;

Wardley, Andrew ;

Conte, PierFranco ;

Miles, David ;

Bianchi, Giulia ;

Cortes, Javier ;

McNally, Virginia A. ;

Ross, Graham A. ;

Fumoleau, Pierre ;

Gianni, Luca .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) :1138-1144

[26] Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: A randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group [J].

Bastholt, L ;

Dalmark, M ;

Gjedde, SB ;

Pfeiffer, P ;

Pedersen, D ;

Sandberg, E ;

Kjaer, M ;

Mouridsen, HT ;

Rose, C ;

Nielsen, OS ;

Jakobsen, P ;

Bentzen, SM .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1146-1155

[27] FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer [J].

Bergh, Jonas ;

Jonsson, Per-Ebbe ;

Lidbrink, Elisabet Kerstin ;

Trudeau, Maureen ;

Eiermann, Wolfgang ;

Brattstrom, Daniel ;

Lindemann, Justin P. O. ;

Wiklund, Fredrik ;

Henriksson, Roger .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) :1919-1925

[28] Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial [J].

Biganzoli, L ;

Cufer, T ;

Bruning, P ;

Coleman, R ;

Duchateau, L ;

Calvert, AH ;

Gamucci, T ;

Twelves, C ;

Fargeot, P ;

Epelbaum, R ;

Lohrisch, C ;

Piccart, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) :3114-3121

[29] Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study [J].

Blackwell, Kimberly L. ;

Burstein, Harold J. ;

Storniolo, Anna Maria ;

Rugo, Hope S. ;

Sledge, George ;

Aktan, Gursel ;

Ellis, Catherine ;

Florance, Allison ;

Vukelja, Svetislava ;

Bischoff, Joachim ;

Baselga, Jose ;

O'Shaughnessy, Joyce .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2585-2592

[30] Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer [J].

Blackwell, Kimberly L. ;

Burstein, Harold J. ;

Storniolo, Anna Maria ;

Rugo, Hope ;

Sledge, George ;

Koehler, Maria ;

Ellis, Catherine ;

Casey, Michelle ;

Vukelja, Svetislava ;

Bischoff, Joachim ;

Baselga, Jose ;

O'Shaughnessy, Joyce .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) :1124-1130

← 1 2 3 4 5 6 7 8 9 10 →